ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q2Scopus Q1SCImago #1,959Gold OA

Tumour Virus Research

Identifier (ISSN):2666-6790(Print)
•
Publisher:Elsevier
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
3.8↓ -4.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Tumour Virus Research

WoS Q2
258114.320234.720248.120253.82026
Annual Impact Factor Metric
Current (2026):3.8
Scopus SJR & RankScopus Q1
1.693
#1,959

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
42

42 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation Rate4.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
13articles/year
100% Gold OA•100% Original Research

Aims & Scope

Tumour Virus Research (ISSN: 2666-6790) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.693 (Q1), an H-index of 42.

Topics Covered (Recognized by AI)
Medicine91.4%Biology91.4%Internal medicine85.7%Genetics80%Virology68.6%Immunology60%Cancer60%Pathology57.1%Biochemistry42.9%Chemistry42.9%Cervical cancer37.1%Human papillomavirus37.1%Family medicine31.4%Virus31.4%Gene28.6%Human immunodeficiency virus (HIV)25.7%Surgery22.9%HPV infection22.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

VIROLOGY

Q2
Rank12/44
IndexESCI
JCIESCI2026

VIROLOGY

Q1
Rank2/44
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

6 year
2026Latest
IF3.8
Articles / Year13
Total Citations2
2025
IF8.1
Articles / Year22
Total Citations75
2024
IF4.7
Articles / Year32
Total Citations171
2023
IF4.3
Articles / Year21
Total Citations383
2022
IF—
Articles / Year15
Total Citations711

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,959Scopus Q1SCImago Profile
Scopus Coverage:2021-2025
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.693

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.55

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,517 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations442
3-Year Documents55
Citable Documents55

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ1
VirologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区VIROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Tumour Virus Research (ISSN: 2666-6790) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.693 (Q1), an H-index of 42.

The journal enforces rigorous peer evaluation with an annual output of approximately 13 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,517 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 61f36db6-f1f6-4b93-a477-9e7c3fa4321f
Database Updated: 2026-10-16